FDA Approved: SORAFENIB — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Sorafenib from Teva Pharmaceuticals, indicating regulatory action for the generic product. Sorafenib is used to trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Carcinoma
• Hepatocellular Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

SUPPL AP for SORAFENIB (SORAFENIB)